Kringle Pharma, Inc. (4884.T)
JPY 814.0
(-0.73%)
JPY 814.0
(-0.73%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -854.15 Million JPY | -157.41% |
| 2022 | -331.82 Million JPY | -10.18% |
| 2021 | -301.16 Million JPY | -155.59% |
| 2020 | -117.83 Million JPY | 60.99% |
| 2019 | -302.05 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -152.2 Million JPY | 22.63% |
| 2024 Q1 | -169.48 Million JPY | 38.49% |
| 2024 Q2 | -196.73 Million JPY | -16.08% |
| 2023 Q4 | -275.52 Million JPY | -4.73% |
| 2023 FY | -854.15 Million JPY | -157.41% |
| 2023 Q3 | -263.07 Million JPY | -66.81% |
| 2023 Q1 | -157 Million JPY | -528.23% |
| 2023 Q2 | -157.7 Million JPY | -0.45% |
| 2022 FY | -331.82 Million JPY | -10.18% |
| 2022 Q4 | -24.99 Million JPY | 0.0% |
| 2021 FY | -301.16 Million JPY | -155.59% |
| 2020 FY | -117.83 Million JPY | 60.99% |
| 2019 FY | -302.05 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 322.435% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -62.104% |
| GNI Group Ltd. | 8.09 Billion JPY | 110.553% |
| Linical Co., Ltd. | 338.26 Million JPY | 352.509% |
| Trans Genic Inc. | 4.08 Million JPY | 21009.449% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 40.599% |
| Soiken Holdings Inc. | -662.2 Million JPY | -28.986% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 718.256% |
| AnGes, Inc. | -7.43 Billion JPY | 88.516% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 33.691% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 88.125% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 557.514% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -9.506% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 25.913% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 29.351% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -5.138% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -163.902% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 29.989% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 39.936% |
| PeptiDream Inc. | 3.03 Billion JPY | 128.136% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 55.938% |
| Ribomic Inc. | -1.02 Billion JPY | 16.606% |
| SanBio Company Limited | -2.64 Billion JPY | 67.695% |
| Healios K.K. | -3.82 Billion JPY | 77.658% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 26.876% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 42.659% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 40.244% |
| StemRIM | -2.02 Billion JPY | 57.757% |
| CellSource Co., Ltd. | 923.14 Million JPY | 192.527% |
| FunPep Company Limited | -933.41 Million JPY | 8.492% |
| Stella Pharma Corporation | -763.74 Million JPY | -11.837% |
| TMS Co., Ltd. | -960.04 Million JPY | 11.03% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 24.412% |
| Cuorips Inc. | -632.18 Million JPY | -35.111% |
| K Pharma,Inc. | 260.33 Million JPY | 428.103% |
| Takara Bio Inc. | 1.48 Billion JPY | 157.713% |
| ReproCELL Incorporated | -31.41 Million JPY | -2618.927% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 3338.119% |
| StemCell Institute Inc. | 310.98 Million JPY | 374.663% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 696.603% |
| CellSeed Inc. | -846.53 Million JPY | -0.9% |